The NDR event will take place from June 22 to 24, 2026, as visits to institutional investors in Seoul.
The purpose is to enhance investor understanding through explanation of subsidiary Verismo Therapeutics' key business and Q&A.
This IR event does not involve any capital change or financial impact, so its effect on short-term stock price is expected to be minimal.
[AI Summary]HLB InnoVation holds an NDR to introduce the business of its subsidiary Verismo Therapeutics, but it is merely a routine IR activity with no capital raising or shareholder value changes, making it a neutral event for the stock price.